Dr. Beth-Ann G. Coller is a retired pharmaceutical executive with more than 30 years of post-doctoral vaccine development experience. She received her B.S. from Norwich University in 1981, M.S. from the University of Dayton in 1986, and PhD from the University of Nebraska Medical Center in 1993. She spent 30 years working in small biotech and large pharmaceutical firms in vaccine development with a particular focus on viral vaccines and vaccines for tropical diseases. Most recently she led development teams for Ebola and dengue vaccine candidates at Merck & Co., Inc., Rahway, NJ, USA. She was a long-standing member of the American Society Tropical Medicine and Hygiene and the American Society for Virology. Despite retiring at the end of 2023, she continues to support important public health initiatives including serving on the Scientific Advisory Committee for the Coalition for Epidemic Preparedness Innovation and others.